United States · General news · Time

A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%

Published by Time · United States 9 h ago

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach to treating the cancer.

Read the full article on Time Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (time.com)

Also worth reading

Chris LaCivita and James Blair donate full Bosnian consulting fee to Trump presidential library

Hegseth staff damaged WWII-era Eisenhower globe trying to move it to his office

At least 16 dead when powerful 7.0 magnitude earthquake strikes Tibet

RFK Jr. adviser Calley Means resigns amid growing MAHA discontent over lack of progress

Rollins: Trump administration going ‘full-bore ahead’ on Forest Service reorganization

‘If Anything Happens to This Guy … Everyone Is Screwed’